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Abstract
nfxB encodes a negative regulator of the mexCD-oprJ genes for drug efflux in the opportunistic pathogen Pseudomonas
aeruginosa. Inactivating mutations in this transcriptional regulator constitute one of the main mechanisms of resistance to
ciprofloxacin (Cipr). In this work, we evaluated the use of nfxB/Cipr as a new test system to study mutation spectra in P.
aeruginosa. The analysis of 240 mutations in nfxB occurring spontaneously in the wild-type and mutator backgrounds or
induced by mutagens showed that nfxB/Cipr offers several advantages compared with other mutation detection systems.
Identification of nfxB mutations was easy since the entire open reading frame and its promoter region were sequenced from
the chromosome using a single primer. Mutations detected in nfxB included all transitions and transversions, 1-bp deletions
and insertions, .1-bp deletions and duplications. The broad mutation spectrum observed in nfxB relies on the selection of
loss-of-function changes, as we confirmed by generating a structural model of the NfxB repressor and evaluating the
significance of each detected mutation. The mutation spectra characterized in the mutS, mutT, mutY and mutM mutator
backgrounds or induced by the mutagenic agents 2-aminopurine, cisplatin and hydrogen peroxide were in agreement with
their predicted mutational specificities. Additionally, this system allowed the analysis of sequence context effects since point
mutations occurred at 85 different sites distributed over the entire nfxB. Significant hotspots and preferred sequence
contexts were observed for spontaneous and mutagen-induced mutation spectra. Finally, we demonstrated the utility of a
luminescence-based reporter for identification of nfxB mutants previous to sequencing analysis. Thus, the nfxB/Cipr system
in combination with the luminescent reporter may be a valuable tool for studying mutational processes in Pseudomonas
spp. wherein the genes encoding the NfxB repressor and the associated efflux pump are conserved.
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Introduction
Mutation is an essential cellular process that contributes to the
genetic variability and acts as the driving force of evolution.
Several processes are involved in mutagenesis in bacteria, such as
erroneous replication and DNA damage by endogenous and
exogenous agents, which in turn are tolerated and/or repaired
using different mechanisms [1]. Much effort has been devoted to
understand these complex processes, which have been preferen-
tially studied in Escherichia coli. For example, genetic analysis of
mutator and antimutator genes has been used to define the
molecular mechanisms of spontaneous mutagenesis in E. coli [2].
However, although these processes are evolutionarily well
conserved, it has been suggested that there are considerable
differences in the mechanisms leading to mutation among bacteria
[1].
The genus Pseudomonas encompasses one of the most diverse and
ecologically significant groups of bacteria [3]. Members of this
genus are capable of thriving in highly diverse ecological niches
due to their versatile metabolic capacity and broad potential for
adaptation to fluctuating environmental conditions. This unique
feature of Pseudomonas spp. implies a remarkable degree of genomic
diversity and genetic adaptability to customize its genome to fit the
requirements for survival in diverse niches [4]. In this regard,
chronic airway infection by P. aeruginosa is the best studied
adaptation to a natural environment. This microorganism causes
severe acute nosocomial-acquired infections in immunocompro-
mised patients, and it significantly contributes to the development
and progression of the chronic pulmonary disease in cystic fibrosis
(CF) patients [5]. Long-term persistence in the lung environment
involves physiological changes [6] and an intense genetic
adaptation frequently achieved by loss-of-function mutations in
global regulatory genes that leads to an enhanced antimicrobial
resistance, altered virulence and specific metabolic adaptation [7].
It has been proposed that these genetic changes are caused by
exposure to the oxidative stress prevailing in the CF lung [8]. In
addition, a relevant role of mutator strains in the genetic
adaptation of P. aeruginosa to the airways has been suggested in
several studies [9]. These mutator strains show defects in the DNA
mismatch repair system (MMR-; mutS, mutL or uvrD genes) [10] or
the DNA oxidative lesions repair system (GO-; mutT, mutY or mutM
genes) [11]. Nevertheless, the molecular mechanisms contributing
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e66236
to mutagenesis and adaptation of P. aeruginosa are poorly
understood to date.
Mutation detection systems are a very important tool to
elucidate the underlying molecular events leading to mutagenesis
in bacteria. At present, a limited number of test systems are
available to analyze mutagenic processes in Pseudomonas spp. For
example, a plasmid-based system to study mutations in P. putida
relies on the transcriptional activation of the promoterless phenol
degradation operon pheBA [12]. The phenol-utilizing mutants
mainly accumulate the GC.TA transvertion, although deletions
from 2-bp to 23-bp, and transposition of the mobile DNA
elements Tn4652 and IS1411 are also detected, which result in the
creation of a sequence similar to the s70-specific promoter
consensus for transcription of the pheBA operon. In addition, a set
of plasmids containing a silent pheA gene was developed for
selection of revertant P. putida cells able to grow on phenol [13].
Different base substitutions and a 1-bp deletion within pheA are
detected using these plasmids. A GFP-based mutation detection
plasmid tests the reversion of a 1-bp insertion in P. aeruginosa [14].
The rpoB gene was used to characterize spontaneous mutations in
the chromosome of P. aeruginosa and P. putida [15]. The highly
conserved rpoB gene, that encodes the b subunit of RNA
polymerase, is the target of mutations leading to rifampicin
resistance (Rifr) in both Pseudomonas spp. The rpoB/Rifr system
senses base substitutions that cause amino acid changes in the
central rifampicin binding pocket (cluster I–III) or the N-terminal
cluster in RNA polymerase. Finally, a new test system based on the
transcriptional control of the phenol degradation genes pheBA by
the E. coli Ptac promoter and the LacI repressor was employed in P.
putida [16]. The phe-lacI system is randomly inserted into the
chromosome allowing detection of different mutations that
inactivate lacI or alter the lac operator sequence.
In the present work, we evaluated the use of the chromosomal
nfxB gene as a new target for analyzing mutation spectra in P.
aeruginosa. nfxB, which is located upstream of mexCD-oprJ but
divergently transcribed from this operon, encodes a transcriptional
repressor that regulates MexCD-OprJ and its own expression by
binding to the nfxB-mexC intergenic region [17,18]. Previous
studies suggested that mutations within nfxB impair or abolish the
NfxB repressor activity leading to overexpression of the MexCD-
OprJ efflux pump and resistance to fluoroquinolone antibiotics
such as ciprofloxacin (Cipr) [17–19]. To validate the nfxB/Cipr
system, we sequenced nfxB in 240 Cipr mutants derived from the
wild-type and mutator strains or treatment with mutagenic agents.
A broad range of mutations was observed in nfxB including all base
substitutions, 1-bp deletions and insertions, .1-pb deletions and
duplications. Localization of mutated residues on a tridimensional
structural model of NfxB generated ad-hoc and analysis of the
plausible consequences on protein structure/function supported a
loss-of-function effect for these mutations. In addition, the nfxB
mutation spectra observed in different mutator backgrounds or
induced by mutagenic agents were consistent with the previously
characterized mutational specificities. Finally, we demonstrated
the efficacy of a luminescence-based reporter to detect nfxB
mutants previous to the sequencing analysis.
Results
Sequence analysis of nfxB in ciprofloxacin resistant clones
In order to evaluate the use of nfxB as a new target to analyze
mutation spectra, we screened a large collection (240) of
ciprofloxacin resistant (Cipr) clones derived independently from
different genetic backgrounds (wild-type, mutS, mutT, mutY and
mutM) or treatment with mutagens (2-aminopurine, cisplatin or
hydrogen peroxide). PCR amplification and further sequencing of
the entire open reading frame (564-bp) and promoter region (160-
pb) of nfxB from these Cipr clones revealed that different mutations
occurred within this gene including each of the six base
substitutions, 1-bp deletions and insertions, .1-pb deletions and
duplications (Table S1). We detected 71 base substitutions in 62
different sites (Table S1), which were distributed over the entire
gene with preference at regions spanning from 100-bp to 125-bp
and 525-bp to 550-bp (Figure 1A). Transitions and transversions
occurred at 37 and 32 different sites, respectively (Table S1).
Deletions and insertions of 1-bp were observed in 23 distinct
positions that were distributed across nfxB more homogenously
than base substitutions (Figure 1A). In addition, we detected
deletions and duplications ranging from 2-bp to 302-pb (Table
S1). Both mutation types involved nucleotides spanning the entire
gene without any preference for a region (Figure 1B). These results
demonstrate that the nfxB/Cipr system senses a broad range of
mutations.
Mapping of changes on the predicted NfxB structure
Among the nfxB mutations reported in this work (Table S1),
base substitutions generated missense mutations (70%) and
nonsense mutations (27%) that changed 19 different amino acid-
coding codons to premature stop codons. Additionally, we
observed two base substitutions that changed the stop codon to
an amino-acid-coding codon, which may add 67 amino acids to
the C-terminal of NfxB. 1-bp deletions and insertions produced
frameshifts that generated premature stop codons in some cases.
Deletions and duplications of .1-bp removed or added amino
acids to NfxB and, eventually, produced frameshifts.
To assess the localization and possible functional consequences
of missense mutations, and since there is not structural data for
NfxB to date, we generated a 3D-structural model of this repressor
(Figure 2A). The NfxB model was obtained by homology modeling
with MODELLER [20] using the tetrameric crystallographic
structure of the TetR-like transcriptional repressor LfrR (PDB
code: 2V57) [21]. Although there are no evidences of the NfxB
oligomeric state at present, we show the dimeric model since it is
expected that the dimer is the minimal unit able to form the DNA-
binding channel (Figure 2). The predicted structure of the NfxB
monomer displayed an almost entirely a-helical architecture with
63% of residues located in a-helices (Figure 2A and 3). The
secondary structure of NfxB predicted using JPred [22] also
showed a high proportion (70%) of residues in a-helices whose
positions were comparable to that showed in the model (Figure
S1). Nine a-helices were identified in the NfxB model (Figure 2A).
The C-terminal helices a4 to a8 were arranged in three layers,
wherein helices a8 and a9 (residues V143 to L178) corresponded
to the LfrR C-terminal helices involved in protein dimerization
[21]. In addition, a large positive charged surface was visualized
on the N-terminal loop between helices a1 and a2 and the helices
a2 and (3 (residues R21 to F43) when the electrostatic properties of
NfxB were determined using APBS [23] (Figure 2B). This
correlated with the localization of the DNA-binding domain in
the N-terminal helices of LfrR [21]. Thus, the N-terminal region
spanning residues R21 to F43 could form the putative DNA-
binding channel in the NfxB dimer.
Based on the NfxB model, we determined that 40% and 24% of
missense mutations affected residues located at the putative DNA-
binding channel and dimerization surface, respectively (Figure 3).
Furthermore, it was possible to distinguish groups of variants on
the basis of their effect on structure or function. The first one,
which accounts for 46% of missense mutations, corresponded to
substitutions of different amino acids for proline (Table S1). A high
nfxB/Cipr System for Mutation Analysis
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proportion (83%) of these mutations fell into predicted a-helices
(Figure 3). Since proline acts as a structural disruptor of regular
secondary structure elements such as a-helices [24], these changes
could be altering protein folding or structure. The other group
(42% of missense mutations) involved changes to residues that
differ in polarity or charge from the original one (Figure 3 and
Table S1). These mutations mainly affected residues forming the
probable DNA-binding channel, and thus, they could alter NfxB
electrostatic properties and DNA binding. All together, these data
support that the detected mutations in nfxB may produce loss-of-
function changes in the NfxB repressor.
Characterization of spontaneous and mutagen-induced
mutation spectra in different genetic backgrounds using
the nfxB/Cipr system
I- Wild type strain. We analyzed 93 spontaneous mutations
isolated from the wild-type (WT) strain PAO1 (Table S1). The
mutation spectrum was composed of all base substitutions (53%),
1-bp insertions and deletions (19%), .1-bp deletions (18%) and
duplications (8%) (Figure 4 and Table S2). Among base
substitutions, the GC.AT transition and the AT.CG transver-
sion were mainly detected. Base substitutions occurred in 21
Figure 1. Distribution of mutations in nfxB. The position of all mutations detected in nfxB among 240 Cipr clones derived independently from
different genetic backgrounds or treatment with mutagens is plotted. (A) The number of base substitutions (blue bars) and 1-bp deletions and
insertions (red bars) detected at each nucleotide position of the open reading frame is shown. (B) .1-bp deletions (red bars) and duplications (blue
bars) are displayed over the open reading frame (black bar) and promoter region (grey bar) of nfxB.
doi:10.1371/journal.pone.0066236.g001
Figure 2. 3D-structural model of NfxB. (A) Ribbon representation of the homology-modeled NfxB dimer based on the TetR-like transcriptional
repressor LfrR. Helices a1–a3 are shown in blue, a4 in light blue, a5–a7b in green, and a8 and a9 are in yellow. N-terminal helices a1 to a3 and C-
terminal helices a8 and a9 corresponded to LfrR helices involved in DNA-binding and dimerization, respectively. (B) Front (above) and top-down
(below) visualization of electrostatic potential distribution in the NfxB dimer as determined using APBS. Positive and negative potentials are indicated
in blue and red, respectively. Note that a large positive charged surface is located on the N-terminal loop between helices a1 and a2 and helices a2
and a3, which could form the putative DNA-binding channel in the NfxB dimer.
doi:10.1371/journal.pone.0066236.g002
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different sites, wherein nucleotide 115 represented a significant
hotspot (p-value,0.05) comprising 35% of all base substitutions
(Table S1). This mutation hotspot showed exclusively the
AT.CG transition. The most mutable dinucleotides were CA
and AC, which was due to the presence of the hotspot at
nucleotide 115 within the CAC sequence (the mutated nucleotide
is indicated in bold, Tables S1 and S3). Insertions and deletions of
1-bp were detected in 16 different positions located within
mononucleotide runs, as it has frequently been reported in
previous works, and outside of runs (Table S1). Deletions and
duplications of different sizes (2-bp to 302-bp) were observed,
however small ones (,15-bp) were most frequently detected
(Table S1).
II- Mutator strains. To test the accuracy of the nfxB/Cipr
system for detecting the mutational specificities displayed by
different mutator strains, we analyzed the nfxB mutation spectrum
in MMR- and GO-deficient strains. First, mutation rates per
replication to Cip resistance were calculated for each mutator
strain (Table 1). When compared to the WT strain, mutation rates
of the mutS and mutT strains were greatly increased whereas the
mutY and mutM strains showed a mild mutator phenotype. Then,
nfxB was sequenced from Cipr colonies derived from each mutator
strain (Table S1). For the mutS and mutT strains, a luminescence-
based reporter was employed to identify nfxB mutants since a
proportion of the Cipr colonies were mutated in nfxB (see below).
In the mutS background, transitions were dominant accounting
for 92% of mutations (Figure 4 and Table S2). The AT.GC
transition was preferentially promoted in this genetic background
since it was increased ,17-fold relative to the WT strain.
Mutation hotspots were observed at nucleotides 86 and 260 (p-
value,0.05), which only showed the AT.GC transition. The CT
and TG dinucleotides were most frequently mutated, as
determined using iMARS [25] (Table S3). Both dinucleotides
were almost exclusively present in sites undergoing the AT.GC
transition. Visual inspection of sequences surrounding the mutated
nucleotide revealed that this mutation occurred in 14 different sites
of nfxB, where 9 had the CTG trinucleotide (which included the
CT and TG dinucleotides; the mutated nucleotide is indicated in
bold) (Table S1). Conversely, AT.GC transitions were not
observed in CTG sequences in the WT strain (Table S1). In the
mutT strain, the AT.CG transversion was almost exclusively
observed comprising 88% of all mutations (Figure 4 and Table
S2). The frequency of this transversion was increased ,4-fold
Figure 3. Amino acid substitutions in NfxB. Amino acid changes in
NfxB caused by missense mutations are indicated with the one letter
nomenclature. Amino acid substitutions for proline are shown in red,
and changes to residues that differ in polarity or charge from the
original one are depicted in blue. The secondary structure obtained
from the NfxB homology model is shown (Nomenclature H: Helix; T:
Turn; -: Coil). The nine a-helices are numbered from a1 to a9.
doi:10.1371/journal.pone.0066236.g003
Figure 4. Spontaneous and mutagen-induced mutations in
nfxB. The nfxB mutations detected in the wild-type (WT) and mutator
strains (mutS, mutT, mutY and mutM), and the WT strain after exposure
to the mutagens 2-aminopurine (2AP), cisplatin (CPT) and hydrogen
peroxide (HP) are summarized. The percentage of each mutation type
relative to the total number of mutations detected for each strain or
treatment is plotted using a color code.
doi:10.1371/journal.pone.0066236.g004
Table 1. Mutation rates to ciprofloxacin resistancea.
Strain Mutagen m (CL) Normalized rateb
WTb – 4.3 (2.3–7.2)610210 1
mutS – 3.4 (2.5–4.6)61026 7907
mutT – 4.6 (4.0–5.0)61026 10698
mutY – 2.0 (1.0–3.2)61028 47
mutM – 9.3 (3.6–16.4)61029 22
WTb – 1.8 (1.1–2.7)61029 1
WT 2AP 1.9 (1.4–2.5)61028 11
WT CPT 2.8 (1.7–4.3)61029 2
WT HP 2.0 (1.3–2.8)61029 1
aMutation rates (m) per replication and 95% confidence limits (CL) were
calculated as described in Material and Methods. Mutation rates for the WT and
mutator (mutS, mutT, mutY and mutM) strains were calculated at 1.0 mg/ml Cip.
Assays with 2-aminopurine (2AP), cisplatin (CPT) and hydrogen peroxide (HP)
were performed at 0.5 mg/ml Cip. bMutation rates calculated for the WT strain at
each set of experiment (mutator strain and mutagen assessment) were used for
data normalization.
doi:10.1371/journal.pone.0066236.t001
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when compared to that observed in the WT strain. The majority
(89%) of AT.CG occurred in CA, AG and AA dinucleotides at
10 different sites within nfxB (Tables S1 and S3). This transversion
was detected in CA dinucleotides in the WT strain, but it almost
exclusively occurred at nucleotide 115 (Table S1). The GC.TA
transversion was the unique mutation detected in the mutY strain,
which was increased ,33-fold in this genetic background relative
to the WT strain (Figure 4 and Table S2). 80% of this transversion
occurred in the GA dinucleotide (the mutated nucleotide is
indicated in bold; Table S1). Transversions dominated the
mutation spectrum in the mutM strain (Figure 4 and Table S2).
The AT.CG, GC.TA and GC.CG mutations were detected in
70% of the Cipr clones isolated from this mutator strain. Among
these transversions, GC.TA and GC.CG were promoted since
they were increased ,7- and ,10-fold, respectively, over the WT
level.
III- Wild type strain exposed to mutagenic agents. P.
aeruginosa WT cells treated with the base analog 2-aminopurine
(2AP) showed a modest increment of mutation (Table 1).
Conversely, treatment with cisplatin (CPT) or hydrogen peroxide
(HP) had no effect on the mutation rate of the WT strain (Table 1).
Cell exposure to 2AP resulted in a shift in the mutation spectrum
to transitions (90%) (Figure 4 and Table S2). The AT.GC and
GC.AT mutations were increased ,5- and ,4-fold upon 2AP
treatment. A high proportion (86%) of the GC.AT transitions
occurred in the CC dinucleotide whereas AT.GC was detected
in the CTG trinucleotide (the mutated nucleotide is indicated in
bold; Table S1). Although CPT and HP did not produce an
increase of mutation rates at the tested concentrations, both
mutagens induced changes in the nature of mutations. The
AT.TA, AT.CG and GC.TA base substitutions, 1-bp
insertions and deletions, and .1-bp deletions were detected in
CPT exposed cells (Figure 4 and Table S2). When compared with
the mutation spectrum observed in the WT strain, AT.TA and
GC.TA were increased ,3- and ,6-fold, respectively. Base
substitutions (86%) were mainly present at sites involving adjacent
G and A nucleotides (Table S1). The sequence context preferences
observed in the 2AP- and CPT-induced spectra were not detected
in the spontaneous spectrum of the WT strain (Table S1). In cells
treated with HP, the nfxB mutation spectrum mainly included
GC.AT and AT.CG, and .1-bp deletions (Figure 4 and Table
S2). Deletions were increased from 18% to 42% after exposure to
HP.
In conclusion, the mutation spectrum characterized for each
mutator background and mutagen treatment was notably different
from that observed in the WT strain. In addition, the observed
changes were consistent with the mutational specificities previously
reported (see Discussion) indicating that the nfxB/Cipr system is
able to accurately sense modifications of the mutagenic processes
occurring in P. aeruginosa cells.
A luminescence-based reporter for detecting nfxB
mutants
The molecular bases of resistance to Cip in P. aeruginosa are
mutations in gyrA and parC, that encode DNA gyrase and DNA
topoisomerase IV, respectively, and mutations in genes encoding
the transcriptional regulators of multidrug efflux pumps like nfxB
[26]. We demonstrated in a previous study that different resistance
mutations are observed in Cipr subpopulations of the mutS and
mutT strains by sequencing gyrA, parC and nfxB [27]. A fraction of
these Cipr subpopulations corresponds to nfxB mutants, which
varied with the Cip concentration used for selection. In the present
work, we used a chromosomal luminescence-based reporter for
identification of nfxB mutants prior to sequencing analysis. This
reporter, previously validated in P. aeruginosa, was achieved by
fusing the mexC promoter to the luxCDABE operon present in the
pUC18-mini-Tn7T-Gm-lux delivery transposon vector that inte-
grates this fusion at the attTn7 chromosomal site (see Materials
and Methods) [27,28]. Thus, the luxCDABE operon is normally
repressed at a basal level by endogenous NfxB. Loss-of-function
mutations in nfxB induce luxCDABE expression, which allows
detection of nfxB mutants by the acquisition of an increased
luminescent phenotype [27]. For the mutT strain, 43% and 70% of
colonies with increased luminescence were observed at 0.5 and
1.0 mg/ml Cip, respectively (Figure 5A). At these Cip concentra-
tions, the percentage of colonies with increased luminescence was
30% and 10% for the mutS strain. All selected colonies exhibiting
an increased luminescence showed a stable phenotype and were
mutated in nfxB, as revealed by sequencing analysis (61 and 32
colonies analyzed for mutS and mutT, respectively) (Table S1).
Conversely, nfxB was not mutated in colonies showing a
background luminescence (10 colonies analyzed for each mutator
strain). When we inserted the luminescent reporter into the
chromosome of the WT strain (selected at 0.5 and 1.0 mg/ml Cip,
and at 0.5 mg/ml Cip after exposure to mutagens) and mutY and
mutM mutators (selected at 1.0 mg/ml Cip), 100% of the Cipr
clones exhibited an increased luminescence phenotype (data not
shown). This was consistent with the fact that all Cipr colonies
selected for sequencing analysis were mutated in nfxB (Table S1).
The luminescent reporter was used in our previous study to
analyze the emergence of nfxB mutants during cell growth in solid
media containing sub-inhibitory Cip concentrations (0.06 mg/ml
for the WT strain, and 0.4 mg/ml for the mutS and mutT strains)
[27]. ,0.06% and 0.3% of nfxB mutants emerged in WT and
mutator populations, respectively [27]. For example, exposure of
mutT cells to 0.4 mg/ml Cip induced the emergence of colonies
with an increased luminescence after 56h of incubation, which
were not previously observed at 24h of incubation (Figure 5B and
5C). This increased luminescence was detected in a small external
sector of the colonies (see arrows in Figure 5C). When these mixed
colonies were further isolated on LB plates, two distinct
populations of cells with either low or high luminescence were
observed. Sequence analysis indicated that only the most
luminescent population was mutated in nfxB (data not shown).
Colonies with an increased luminescence were not observed in
mutT cells in the absence of Cip at the tested conditions (data not
shown). Stimulation of nfxB mutagenesis at sub-inhibitory Cip
levels may be produced by a transient increase in the mutation rate
Figure 5. Identification of nfxB mutants using a luminescence-
based reporter. (A) Colonies of the mutT strain selected at 1.0 mg/mL
Cip after 48 h of incubation. Examples of colonies with basal (non-
mutated) and increased (nfxB mutants) luminescence are indicated
(horizontal and vertical arrows, respectively). (B–C) Colonies of the mutT
strain selected at a subinhibitory Cip concentration (0.4 mg/mL) after 24
h (B) and 56 h (C) of incubation. Detection of a subpopulation of cells
with increased luminescence arising from colonies with basal lumines-
cence indicates the emergence of nfxB mutants (examples are indicated
by arrows).
doi:10.1371/journal.pone.0066236.g005
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induced by this antibiotic [27]. This mutagenic effect has been
previously reported for fluoroquinolones and other antibiotics in
different bacterial species [29]. Different mechanisms has been
proposed for induction of mutagenesis such as DNA oxidation due
to an oxidative burst, mutagenic repair of DNA damage by
recombination, induction of error-prone polymerases mediated by
the SOS response or direct interaction with DNA [29].
We demonstrated that this luminescent reporter may be used to
detect subpopulations of nfxB mutants, as showed for the mutS and
mutT strains, and to follow the emergence of nfxB mutants over
time.
Discussion
Understanding molecular mechanisms of mutational processes
requires test systems for monitoring mutation rates and analyzing
mutation spectra. Several mutation detection systems have been
developed for bacteria, however the majority are well suited for
use in E. coli. In recent years, studies have been focused on
mutational mechanisms in other bacteria such as the diverse and
ecologically significant Pseudomonas genus [30]. There are a limited
number of test systems for analyzing mutations in Pseudomonas spp.
Moreover, most of these systems are based on the selection of
mutants capable of growing in phenol [12,13,16], with exception
of the rpoB/Rifr and gfp systems [14,15], and have been applied to
studies of mutational processes in P. putida.
In the present report, we evaluated the use of nfxB as a new
target to analyze mutation spectra in P. aeruginosa. Inactivating
mutations in this gene constitute one of the main mechanisms
leading to ciprofloxacin resistance (Cipr) in this opportunistic
pathogen [17–19]. We demonstrated that the nfxB/Cipr system
exhibits several advantages compared with the previously charac-
terized systems. A simple and unambiguous assignment of
mutations was achieved since the complete open reading frame
and the promoter regions of nfxB are sequenced using a single
primer. Conversely, mutations in rpoB map into clusters I-III or the
N-terminal cluster, and consequently two sequencing reads are
needed to determine mutational sites [15]. In the pheA-lacI
system, 5 primers are used to cover the complete lacI and lac
operator sequences wherein mutations are detected [16]. nfxB
allowed the detection of mutations occurring in the P. aeruginosa
chromosome. Previous studies in E. coli have demonstrated that
mutational processes may operate differently in the chromosome
than extrachromosomal elements under some conditions [31,32].
Therefore, even though this has not been studied in Pseudomonas, it
is important to consider this aspect when a mutational analysis is
carried out. The fact that nfxB is an endogenous gene simplifies the
analysis of mutations. For example, in the pheA-lacI and plasmid-
based systems is necessary to introduce these elements before
selection of mutants. In addition, it is important to examine if
random insertion of the pheA-lacI system into the chromosome
does not alter genes involved in mutational processes.
The nfxB/Cipr system detected different mutation types that
comprised all base substitutions, 1-bp deletions and insertions, and
deletions and duplications ranging from 2- to 302-bp. To compare
this system with the rpoB/Rifr system, we sequenced rpoB in 44
rifampicin resistant clones isolated from the wild-type (WT) strain
PAO1 used in this work (Table S4). As previously reported [15],
the spontaneous rpoB mutation spectrum included almost exclu-
sively three of the six base substitutions: AT.GC, GC.AT and
AT.TA. Therefore, and differently from rpoB that is well suited
for analyzing base substitutions, nfxB is able to detect a broad
range of mutations in the chromosome of P. aeruginosa. This results
from selection of loss-of-function changes in the NfxB repressor.
Based on our 3D-structural model of NfxB, missense mutations
mainly affected residues located at the putative DNA-binding
channel and dimerization surface. Additionally, we predicted two
probable effects of these mutations on NfxB: alteration of its
structure by substitutions of different amino acids for the structural
disruptor proline into predicted a-helices, and its DNA-binding
activity by changing the polarity or charge of residues forming the
putative DNA-binding channel. Amino acid substitutions in NfxB
of P. aeruginosa linked to multidrug resistance phenotypes and
eventually to overexpression of MexCD-OprJ have been previ-
ously reported: R21H [33,34]; A30T [35]; R42G [36]; R42H
[37]; R42C [33]; D56G [33,34]; L62V [35]; R82L [38]; H87R
[39]; Y109H [34]; K132I [33]; K132R [33]; M155R [34] and
N183I [33]. Most of these mutations are positioned in the putative
DNA-binding and dimerization regions predicted in our NfxB
model. Thus, we described inactivating mutations in 33 additional
residues of NfxB.
Different mutagenic processes were detected using the nfxB/
Cipr system since the mutation spectra characterized for each
mutator background and mutagen exposure corresponded to its
recognized mutational specificity. In the mutS-deficient strain,
mutations were almost exclusively transitions and AT.GC was
preferentially promoted as reported in previous studies using rpoB
and lacI targets in E. coli [40,41]. Mutations indentified in GO-
deficient backgrounds correlated with the lack of 8-oxodeoxygua-
nine (8-oxoG) repair. The mutT strain exhibited an increase of the
AT.CG transversion, which is consistent with a deficiency of 8-
oxoG hydrolysis in nucleotide pools by MutT [42,43]. mutM and
mutY mutator strains showed specific GC.TA increases as
expected from the role of MutM and MutY in the repair of 8-
oxoG present in double-stranded DNA [43,44]. A prevalence of
AT.CG and GC.TA was also detected in the mutation spectra
of rpoB from mutT- and mutYM-deficient strains of E. coli,
respectively [40]. These mutations were not observed in rpoB
from mutM and mutT mutator strains of P. aeruginosa [45] indicating
that the rpoB/Rifr system may not be suitable to sense mutations
related to the deficiency of mutM and mutT in P. aeruginosa.
Additionally, the GC.CG transversion was also promoted in the
mutM strain. This base substitution was induced by oxidative stress
in rpoB and lacI from mutM-deficient strains of P. aeruginosa and E.
coli, respectively [45,46]. The base analog 2AP causes AT.GC
and GC.TA transitions by mispairing with C [47]. As predicted,
both mutations were increased in the WT strain after exposure to
this mutagen. This was not observed in rpoB of E. coli where only
GC.TA was induced by 2AP [40]. Treatment with cisplatin
(CPT) produced an increase of AT.TA and GC.TA transver-
sions in the nfxB mutation spectrum from the WT strain. As
showed in previous studies, both mutations were also induced by
this mutagen in E. coli cells [40,48,49]. Hydrogen peroxide (HP)
increased the frequency of deletions involving a small number of
nucleotides (,15-bp) in P. aeruginosa. A previous work demon-
strated that exposure of E. coli cells to HP also promoted the
occurrence of deletions ranging from 2- to 10-bp, however, and
differently to that observed in nfxB, these mutations were detected
within dinucleotide repetitive sequences [50].
Most of test systems employed in Pseudomonas sense mutations in
a limited number of surrounding sequence contexts. Systems based
on the reversion of pheA or gfp only use one site to monitor base
substitutions and a 1-bp deletion [13,14]. Base substitutions occur
in two different sites to activate the transcription of the
promoterless operon pheBA [12] and in 24 sites of rpoB [15].
Changes in 40 sites within lacI and the lac operator are detected
using the pheA-lacI system [16]. On the other hand, numerous
sequence contexts can be analyzed using nfxB. We detected 71
nfxB/Cipr System for Mutation Analysis
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base substitutions in 62 different sites, and deletions and insertions
of 1-bp distributed among 23 distinct positions. This allowed us to
identify mutation hotspots and preferred sequence contexts. In the
spontaneous mutation spectrum from the WT strain, a hotspot
was identified at nucleotide 115 that showed exclusively the
AT.CG transversion. Two AT.GC hotspots were observed at
nucleotides 86 and 260 in the mutS background. In addition, we
found that AT.GC transitions were predominantly detected in
the CTG trinucleotide (the mutated nucleotide is indicated in
bold). The hotspot at nucleotide 86 showed this sequence context
and the hotspot at nucleotide 260 occurred at a CAC trinucleotide
(or GTG in the other strand). Thus, AT.GC mutations were
favored at TG sequences (where T had a 39-G). Similarly,
although AT.GC changes predominantly occur at GT (where T
had a 5’-G) sequences, TG sequences are also preferred in rpoB
and lacI from mutS-deficient strains of E. coli [40,41]. AT.CG was
almost exclusively observed in CA, AG and AA dinucleotides in
the mutT strain, and GC.TA mainly occurred in GA sequences in
the mutY strain. A preference for these sequence contexts are also
observed in rpoB from mutT- and mutYM-deficient strains of E. coli
[40]. For the base analog 2AP, we showed that GC.AT
transitions mainly occurred in CC dinucleotides. This is not in
agreement with previous works showing that a C preceded by a G
is the preferred sequence context for GC.AT transitions in E. coli
cells exposed to 2AP [40,51]. Base substitutions observed in WT
cells treated with CPT were present at sites involving adjacent G
and A nucleotides. The mutagenic agent CPT mainly promotes
1,2-intrastrand cross-links at ApG and GpG sites causing different
base substitutions at these sites [49,52]. Accordingly, the primary
source of CPT-induced mutations was the ApG adduct in nfxB. In
addition, our results showing that CPT induced AT.TA at AG
sites and GC.TA at GA sites by mutating the 59-nucleotide of the
adduct correlate with previous findings [40,49,52].
Along with the advantages demonstrated for the nfxB/Cipr
system, we also showed the utility of a luminescence-based
reporter for identification of nfxB mutants. In this work, we used
this reporter to detect nfxB mutants derived from the mutS and
mutT strains previous to sequencing analysis since a fraction of
both Cipr subpopulations was mutated in this gene. Thus, the
luminescent reporter should be used in bacterial strains or
conditions wherein resistance to Cip is mediated by mutations in
different target genes. For these cases, our luminescent reporter
may be applied as it is contained in a broad-range mini-Tn7
transposon that has been widely used for chromosomal insertion in
Pseudomonas and other bacterial species [28]. In addition, the
luminescent reporter was used to monitor the emergence of nfxB
mutants in cells exposed to sub-inhibitory Cip levels over time
(results from this work and Morero et al. 2011). Similarly, it could
be also employed to follow other stress-induced mutagenic
processes such as those occurring in stationary phase or upon
starvation conditions.
Finally, the use of nfxB/Cipr as a test system could be extended
in a straightforward manner to other P. aeruginosa strains and
probably to other Pseudomonas spp. We found at least 19 putative
orthologous genes to PAO1 nfxB among other P. aeruginosa strains
and species of this genus. Among them, all orthologs found in P.
aeruginosa strains were associated to mexCD-oprJ homologue genes
in the genome and their function in antibiotic efflux was
experimentally demonstrated for some strains (e.g. LESB58 and
UCBPP-PA14 strains). Although functional information about
nfxB orthologs in other Pseudomonas spp. is limited or null, we
observed that they are frequently associated with genes encoding
efflux pumps in the genome (some of them from the resistance
nodulation division) suggesting a role in drug resistance. In
addition to nfxB conservation, all residues affected by missense
mutations were well conserved among nfxB orthologs (Figure S2).
Thus, the nfxB/Cipr system in combination with the luminescent
reporter may be a valuable tool for studying mutational processes
in Pseudomonas spp.
Materials and Methods
Bacterial strains and culture media
P. aeruginosa PAO1 wild-type (WT), and the isogenic mutS, mutT,
mutY and mutM mutator strains were obtained from the University
of Washington Genome Center [53]. Transposon insertion within
the corresponding gene was confirmed by PCR analysis following
the manufacturer’s instructions. Luria-Bertani (LB) or M9 minimal
media were used [54]. To prepare inocula, bacteria were cultured
on agar plates from frozen stocks and sub-cultured in liquid LB
medium overnight with shaking at 240 rpm at 37uC.
Estimation of spontaneous and mutagen-induced
mutation rates
Mutation rates were determined by the modified Luria–
Delbruck fluctuation test [55]. Independent cultures (10–30) were
obtained as follows: P. aeruginosa WT and mutator cells from
overnight cultures were inoculated in LB medium (,300 cells/ml)
and grown to exponential phase (,16109 cells/ml). For 2-
aminopurine (2AP) mutagenesis, the WT strain was cultured in LB
medium as described above in the presence of 500 mg/ml 2AP.
For cisplatin (CPT) and hydrogen peroxide (HP) mutagenesis,
exponentially growing cultures of the WT strain in LB medium
were diluted to 16108 cells/ml into M9 medium and incubated
with 150 mg/mL CPT or 1.5 mM HP for 1 h at 37uC. Cells were
then diluted 1000-fold into fresh LB medium and grown to
exponential phase. After cultures reached late-exponential phase,
aliquots from successive dilutions were plated onto LB agar to
determine the number of viable cells and onto LB containing 0.5
or 1.0 mg/ml ciprofloxacin (Cip) to select resistant cells. Colonies
were scored after 24–48 h. The Ma-Sandri-Sankar (MSS)
maximum-likelihood method was applied to estimate the number
of mutants (m) using the MSS algorithm [56]. Then, the mutation
rate (m) was calculated with the Luria–Delbruck equationm= m/
Nt, where Nt corresponds to the final number of cells in cultures
[55]. Salvador program [57] was used to calculatem and 95%
confidence limits.
Identification of nfxB mutants using a luminescence-
based reporter
A luminescent reporter for detection of the transcriptional de-
repression of the mexCD-oprJ operon was used to identify nfxB
mutant cells [27]. Briefly, a DNA fragment (421-bp) containing the
promoter region of mexC (160-bp) from P. aeruginosa PAO1 was
fused to the luxCDABE operon, and this fusion was inserted into
the attTn7 site of the P. aeruginosa chromosome using the pUC18-
mini-Tn7T-Gm-lux vector [28]. Chromosomal insertions were
confirmed by PCR as recommended in the published protocol.
Luminescence was measured directly from Cip agar plates in a
NightOWL LB 983 luminometer (Berhold Technologies). Colo-
nies with enhanced luminescence exhibited a stable phenotype
when picked up onto LB agar plates.
This reporter was employed to detect nfxB mutants in the mutS
and mutT strains since a proportion of ciprofloxacin resistant (Cipr)
colonies derived from these mutator strains was mutated in nfxB
[27]. This proportion depended on the Cip concentration used for
selection. When ,1000 Cipr colonies were analyzed, 30% and
10% of colonies with increased luminescence were observed at 0.5
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and 1.0 mg/ml Cip for the mutS strain, respectively. At these Cip
concentrations, the percentage of colonies with increased lumi-
nescence was 43% and 70% for the mutT strain. It was not
necessary to use this reporter to identify nfxB mutants in the WT,
mutM and mutY strains. For these strains, nfxB was mutated in all
Cipr colonies analyzed, which was consistent with the observation
that 100% of ,500 Cipr colonies showed an increased lumines-
cence phenotype (WT at 0.5 and 1.0 mg/ml Cip in the absence of
mutagens, and at 0.5 mg/ml Cip in the presence of mutagens;
mutM and mutY at 1.0 mg/ml Cip). Additionally, this reporter was
used to sense the emergence of nfxB mutants in cells of the mutT
strain exposed to sub-inhibitory Cip levels. Approximately 300
cells from 20 independent overnight cultures were applied onto LB
agar plates containing 0.4 mg/ml Cip (6000 total cells). Lumines-
cence of colonies was measured after 24 and 56 h of incubation.
Analysis of the nfxB sequence in ciprofloxacin resistant
mutants
nfxB (Genbank accession number: NC_002516.2; Pseudomonas
Genome Database: PA4600, www.pseudomonas.com) was se-
quenced from colonies selected mainly at 0.5 mg/ml Cip for the
WT (77%) and mutS (84%) strain. Additional sequences were
obtained from colonies selected at 0.06, 0.6 and 1.0 mg/ml Cip for
the WT strain and at 0.4 and 1.0 mg/ml Cip for the mutS strain.
Cipr colonies selected at 0.4 (31%), 0.5 (19%) and 1.0 (50%) mg/
ml Cip were used for the mutT strain. 100% of colonies were
selected at 1.0 mg/ml Cip for the mutM and mutY strains. In assays
with mutagens, the WT strain was selected at 0.5 mg/ml Cip. For
the mutS and mutT strains, nfxB mutants were identified among
Cipr populations using the chromosomal luminescent reporter
described above. nfxB was sequenced in Cipr colonies derived from
independent cultures that were isolated in Cip agar plates to
confirm its decreased Cip susceptibility.
For the WT strain, 0.5 mg/ml Cip was mainly used since the
number of Cipr colonies decreased ,1000-fold at higher
concentrations [27]. All analyzed Cipr clones, selected at different
Cip concentrations (0.06 to 1.0 mg/ml), were mutated in nfxB
indicating that this gene may be the main mutation target
independently of the Cip concentration used for selection. This
was confirmed by inserting the luminescent reporter into the WT
chromosome (see above). For the mutS and mutT strains, 0.5 and
1.0 mg/ml Cip were mainly employed, respectively, since the
number of nfxB mutants was higher at these concentrations [27]
(see above). It is important to note that we did not observe changes
in the nfxB mutation spectra at the different Cip concentrations
used for selection of the WT, mutS and mutT strains. Thus, we
compiled the sequencing data obtained at different Cip concen-
trations for spectra analysis. nfxB mutation analysis for the mutM
and mutY strains was only carried out at 1.0 mg/ml Cip. At this Cip
concentration, all analyzed clones were mutated in nfxB and the
Cipr colonies showed an increased luminescence phenotype when
the luminescent reporter was introduced into the chromosome of
both strains (see above).
The entire open reading frame (564-bp) and the promoter
region (160-bp) of the nfxB gene was amplified by colony PCR with
primers NfxB1 (5’-AGCCATGACACACCCGACCG-3’, comple-
mentary to the nucleotide sequence at positions 146-166 upstream
of the ATG initiator codon) and NfxB2 (5’-TGCCATGCGGC-
GACGAGAGG-3’, complementary to the nucleotide sequence at
positions 42-62 downstream of the TGA stop codon). Amplified
products were purified and sequenced with the NfxB1 primer by
the DNA Sequencing Service of the University of Chicago. All
mutations identified are shown in the Table S1.
The base substitution spectra obtained from the WT, mutS and
mutT strains were statistically analyzed with iMARS [25]. iMARS
was used to examine individual spectra for significant hotspots to
distinguish true mutation hotspots from potential randomly
mutable sites. The approach used by iMARS for identification
of hotspots within individual spectra is based on that described by
Tarone [25]. To identify underlying patterns of target-sequence
context, the relative dinucleotide mutability (RDM) scores for the
12 possible dinucleotides within each spectrum were calculated by
the nearest neighbor analysis used by iMARS (see Table S3). In
addition, the mutation sequence context was examined by
analyzing the five nucleotides upstream and downstream of the
mutational site (see Table S1).
To determine the spontaneous rpoB mutation spectrum from the
WT strain, cells were cultured as described above and plated onto
LB agar containing 100 mg/ml rifampicin. The region corre-
sponding to cluster I and II of rpoB was PCR amplified and
sequenced in 44 independent rifampicin resistant clones using the
primers RpoB1 (5’- AATGGCCGAGAACCAGTTCCG-3’) and
RpoB2 (5’- AAGCCTGGGCGATGACGTGG-3’).
NfxB tertiary structure homology modeling
A tridimensional homology model of NfxB was made using
MODELLER 9v8 [20]. Since BLAST and PSI-BLAST retrieved
homologous sequences with known three-dimensional structure
but a low identity to NfxB, the fold recognition software
pGenTHREADER [58] (http://bioinf.cs.ucl.ac.uk/psipred/) was
used to identify a suitable template structure and to obtain a
target-template sequence alignment. The top hit was the TetR-like
transcriptional repressor LfrR from Mycobacterium Smegmatis in
complex with proflavine (PDB code: 2V57). This repressor, which
is also involved in Cip resistance [21], was used as the model
template. The predicted NfxB amino acid sequence has an identity
of 22% with LfrR.
Initial models were built with automodel class. The model with
the lowest value of the MODELLER objective function was
picked. Evaluation of the model using QMEAN [59] revealed a
loop of poor quality (residues 130 to 140) that corresponded to a
gap in the alignment. This region was further refined using the
loop routine of MODELER [20]. Final refinement was performed
generating 50 additional models, followed by selection of the best
model based on the global QMEAN score [59]. The resulting
model had a good quality and a strong reliability as indicated by a
QMEAN score of 0.7 (range 0–1; where 0 is worst and 1 best).
Secondary assessment of NfxB model was determined using the
knowledge-based method STRIDE [60] and DSSP [61,62] that
uses hydrogen bonded patterns. No significant differences arose
from these two methods. Electrostatic Surface potential was
calculated with APBS [23]. The final model was represented with
VMD (Figure 2A) [63].
Secondary structure of NfxB was predicted using JPred [22]
(Figure S1). Comparison of the NfxB secondary structure
predicted by JPred with that experimentally determined for LfrR
revealed a strong correlation in the alignment supporting the
selection of LfrR as a template for NfxB structure modeling. In
addition, the localization of a high proportion of missense
mutations in the putative DNA-binding and dimerization regions
and the predicted effects of these changes on NfxB function also
supported the obtained model.
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Supporting Information
Figure S1 Secondary structure analysis of NfxB. The
secondary NfxB structure was predicted from amino acid sequence
using JPred. H: Helix; S: Bend; T: Turn.
(TIF)
Figure S2 nfxB sequence conservation in Pseudomonas
spp. Sequence alignment of NfxB from P. aeruginosa PAO1
(PA4600) to some of its putative orthologs from other strains and
species. P. aeruginosa M18 (PAM18); P. aeruginosa UCBPP-PA14
(PA14); P. aeruginosa PA7 (PSPA7); P. fluorescens Pf0-1 (Pfl01); P.
entomophila L48 (PSEEN); P. putida GB-1 (PputGB1); P. putida
KT2440 (PP); P. stutzeri DSM 10701 (PSJM300); P. syringae pv.
phaseolicola 1448A (PSPPH); P. syringae pv. syringae B728a 89
(Psyr); P. syringae pv. tomato DC3000 (PSPTO) and P. fulva 12-X
(Psefu). Sequences were aligned using ClustalW (www.ebi.ac.uk).
All amino acids found to undergo missense mutations among the
Cipr PAO1 clones analyzed in this work are coloured in red.
Amino acids found to undergo missense mutations among
quinolone resistant or mexCD-oprJ overexpressing P. aeruginosa
clones in previous studies are coloured in cyan. Residues detected
both in this work and previous studies are indicated in orange.
(TIF)
Table S1 Mutations in nfxB.
(DOC)
Table S2 Percentage of each nfxB mutationa.
(DOC)
Table S3 RDM scoresa.
(DOC)
Table S4 Mutations in rpoBa.
(DOC)
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